Suspension of trading
Intellipharmaceutics International Inc. Stock Deutsche Boerse AG
Stocks
I4AA
CA4581733090
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0445 EUR | -13.59% |
|
-.--% | - |
| Market Cap | 1.41M 1.22M 1.14M 1.04M 1.97M 134M 2M 13.37M 5.26M 66.82M 5.28M 5.17M 221M | P/E 2021 |
-0.69x | P/E 2022 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 3.65M 3.17M 2.95M 2.71M 5.11M 348M 5.2M 34.7M 13.64M 173M 13.7M 13.4M 574M | EV / Sales 2021 |
-
| EV / Sales 2022 | 70.4x |
| Free-Float |
98.24% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -13.59% |
| 3 years | 0.03 |  | 0.08 |
| 5 years | 0.01 | | 0.18 |
| 10 years | 0.01 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amina Odidi
DFI | Director of Finance/CFO | - | - |
| Comptroller/Controller/Auditor | - | 01/04/2007 | |
| Corporate Officer/Principal | - | 01/02/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Amina Odidi
BRD | Director/Board Member | - | 01/09/2004 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 14/02/24 | Option | Director | 100,000 | 0.3022% | ||
| 13/02/24 | Option | Director | 120,000 | 0.3626% | ||
| 13/02/24 | Option | Executive/Senior Manager | 200,000 | 0.6044% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.59% | -.--% | - | - | 33 | |
| -0.53% | -3.12% | +51.15% | +150.58% | 1,030B | |
| +0.21% | -1.13% | +53.26% | +46.92% | 617B | |
| -2.51% | -2.33% | +32.56% | +66.35% | 455B | |
| +0.06% | +1.17% | +36.21% | +31.25% | 350B | |
| -0.14% | -0.83% | +33.24% | +40.28% | 299B | |
| -0.69% | -0.44% | +9.86% | +14.23% | 265B | |
| -7.37% | -4.31% | -5.69% | -41.99% | 225B | |
| -0.64% | +3.68% | +27.80% | +62.95% | 209B | |
| -0.82% | -0.50% | +13.46% | +69.41% | 163B | |
| Average | -2.11% | +4.83% | +27.98% | +48.89% | 401.41B | |
| Weighted average by Cap. | -0.24% | +4.87% | +36.61% | +70.85% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 65.73K 57.02K 53.07K 48.76K 92.13K 6.27M 93.62K 625K 246K 3.12M 247K 241K 10.35M |
| Net income | -5.15M -4.46M -4.15M -3.82M -7.21M -491M -7.33M -48.93M -19.23M -244M -19.32M -18.9M -810M | -2.89M -2.51M -2.34M -2.15M -4.05M -276M -4.12M -27.5M -10.81M -137M -10.86M -10.62M -455M |
| Net Debt | 1.15M 994K 925K 850K 1.61M 109M 1.63M 10.89M 4.28M 54.42M 4.3M 4.21M 180M | 2.24M 1.95M 1.81M 1.66M 3.14M 214M 3.19M 21.32M 8.38M 107M 8.42M 8.24M 353M |
Employees
11
Sector
Pharmaceuticals
- Stock Market
- Stocks
- IPCIQ Stock
- I4AA Stock
Select your edition
All financial news and data tailored to specific country editions
